Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Steroid avoidance or withdrawal for kidney transplant recipients.

The Cochrane database of systematic reviews·2026
Same author

Erratum to "Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis." Kidney International 2024;106:67-84.

Kidney international·2026
Same author

Safety and Efficacy of Manual and Automated Abdominal Colonic Massage for Chronic Constipation: A Systematic Review and Meta-Analysis.

Clinical and translational gastroenterology·2026
Same author

Plasma-Treated Poly(Lactic Acid): Deciphering the Structure of a Versatile Engineering Material.

ACS omega·2026
Same author

Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation.

Therapeutic drug monitoring·2025

Related Experiment Video

Updated: Jul 6, 2026

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors
06:24

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors

Published on: August 1, 2025

Gene therapy for acute renal failure.

Juan Torras1, Josep M Cruzado, Immaculada Herrero-Fresneda

  • 1Nephrology Service and Laboratory of Experimental Nephrology, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, Barcelona, Spain.

Contributions to Nephrology
|April 9, 2008
PubMed
Summary

Gene therapy and cell therapy show promise for treating acute renal failure (ARF). These innovative biotechnologies leverage genetic engineering and cell expansion to repair kidney damage and improve recovery time.

More Related Videos

Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney
08:53

Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney

Published on: August 9, 2014

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Related Experiment Videos

Last Updated: Jul 6, 2026

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors
06:24

Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors

Published on: August 1, 2025

Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney
08:53

Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney

Published on: August 9, 2014

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Area of Science:

  • Nephrology
  • Biotechnology
  • Molecular Medicine

Background:

  • Understanding of kidney disease at cellular and molecular levels is advancing.
  • Cytokine and growth factor networks are crucial for repairing acute renal failure (ARF).
  • Biotechnology is developing novel therapeutic strategies, including gene and cell therapies.

Purpose of the Study:

  • To examine the prospects of gene therapy for treating acute renal failure (ARF).
  • To review advancements in gene delivery systems for renal applications.
  • To discuss the potential of cell therapy as a tool for gene therapy in kidney disease.

Main Methods:

  • Review of experimental models for gene delivery systems in renal structures.
  • Analysis of technical advances in viral and liposome vector systems.
  • Examination of cell expansion and transplantation techniques for therapeutic purposes.

Main Results:

  • Effective gene therapy strategies for renal structures have been developed in animal models.
  • Intrarenal injection and perfusion of explanted kidneys show efficient renal gene transfer.
  • Gene and cell therapies offer potential for diminishing renal failure and accelerating recovery.

Conclusions:

  • Gene therapy is an encouraging strategy for preventing and treating renal diseases.
  • Cell therapy, as an adjunct to gene therapy, can deliver therapeutic proteins or restore physiological functions.
  • These novel approaches hold promise for improving outcomes in acute tubular necrosis and other renal failures.